Another scenario is a patient who has been using a GLP-1 therapy for a few years, has reached a weight-loss plateau, and is now in the maintenance phase of treatment
This growing shift toward oral therapies is expected to expand market reach and improve access, especially in primary care settings
In 2023 the FDA updated the requirements for some GLP1 drugs to include a warning for ileus, intestinal blockage, a rare, but potentially-fatal complication
particolarmente indicato per sportivi e per chi svolge attivit che richiedono un elevato dispendio energetico, contribuendo inoltre a migliorare la concentrazione e l'attenzione
Hyperuricemia and cardiovascular disease
Step 3: Pair with Antioxidant-Rich Habits Eat sulfur-rich foods (garlic, broccoli) to boost natural glutathione